Feedback / Questions
Undisclosed highly tumour selective bispecific T-cell engager - LabGenius Therapeutics
https://www.businesswire.com/news/home/20251112292702/en/LabGenius-Therapeutics-Announces-Poster-Presentation-at-the-ESMO-Immuno-Oncology-Congress-2025
 
Nov 12, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious